ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-PO269

Deep Learning Allows Automated Analysis of Cystogenesis in Novel Xenopus Animal Models for Autosomal Polycystic Kidney Disease

Session Information

Category: Genetic Diseases of the Kidneys

  • 1101 Genetic Diseases of the Kidneys: Cystic

Authors

  • Naert, Thomas, Universitat Zurich, Zurich, ZH, Switzerland
  • Lienkamp, Soeren S., Universitat Zurich, Zurich, ZH, Switzerland
Background

Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in PKD1 or PKD2 and has an unmet need for new drugs and therapeutic targets. Ideally, these are identified in clinically relevant vertebrate disease models amenable to screening efforts. Further, genome editing simplifies the generation of new animal models for congenital disorders. However, the detailed and unbiased phenotypic assessment of altered embryonic development remains a challenge.

Methods

We employ targeted and unilateral CRISPR/Cas9 editing in order to inactivate pkd1 or pkd2 in the Xenopus developing vertebrate kidney. Cystogenesis is then visualized by whole-mount immunostaining, fluorescent stereomicroscopy, mesoSPIM light-sheet microscopy and advanced U-Net deep learning image processing for automated, unbiased and rapid scoring of kidney pathological states in two and three dimensions.

Results

CRISPR/Cas9 genome engineering in pkd1 and pkd2 elicited cystic malformations in developing renal tubules two-days post-fertilization (p<0.001). We observed cystogenesis across different developmental stages by leveraging an image processing pipeline for automated scoring of ADPKD in Xenopus embryos using deep learning approaches. Using a combination of segmentation and classification deep learning architectures allowed for automated size measurement of kidneys, as well as a qualitative analysis of cystic hallmarks. Our models correlated well with an independent expert on test data (ntest=120; r=0.96; P<0.001). Next, using tissue clearing and light-sheet microscopy approaches, we extended to three-dimensional analysis of cystogenesis. Here we showed that three-dimensional kidney size quantification can be achieved.

Conclusion

By combining light-sheet microscopy and deep learning we provide a framework for higher-throughput and in-depth characterization of novel models for autosomal polycystic kidney disease.

MesoSPIM light-sheet microscopy allows for whole-embryo imaging of Xenopus tropicalis embryos. Wild-type (top) embryos develop normal kidneys, pkd1 mutants (bottom) reveal cystogenesis.